Search

Your search keyword '"A. Van Gorp"' showing total 8,502 results

Search Constraints

Start Over You searched for: Author "A. Van Gorp" Remove constraint Author: "A. Van Gorp"
8,502 results on '"A. Van Gorp"'

Search Results

1. Deep Sylvester Posterior Inference for Adaptive Compressed Sensing in Ultrasound Imaging

2. How Important Is Studying Languages for Undergraduate Students and Why (Not) Study Languages?

3. Learning Structured Compressed Sensing with Automatic Resource Allocation

4. A generative foundation model for five-class sleep staging with arbitrary sensor input

5. EvolvED: Evolutionary Embeddings to Understand the Generation Process of Diffusion Models

6. Toward Scalable Content Generation for Gamified mHealth Interventions: The Evaluation of LLM-Generated Goals on User Engagement

7. Non-reciprocal breathing solitons

8. Positive and negative survivor-specific psychosocial consequences of childhood cancer: the DCCSS-LATER 2 psycho-oncology study

13. Multipotent adult progenitor cells prevent functional impairment and improve development in inflammation driven detriment of preterm ovine lungs

14. Primary School Children's Conflicted Emotions about Using Their Heritage Languages in Multilingual Classroom Tasks

15. The Mapping Imaging Spectrometer for Europa (MISE)

17. Towards Augmenting Mental Health Personnel with LLM Technology to Provide More Personalized and Measurable Treatment Goals for Patients with Severe Mental Illnesses

18. 'Mister What Time Is It?' Preparing Teachers for Border Schools: The Case of the Arizona Borderlands

19. Removing Structured Noise with Diffusion Models

20. Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery

21. Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial

22. First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial

23. Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors

27. Benign ovarian mass

29. Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics

32. Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery

33. Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary

37. How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting

38. ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer

39. Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup

40. Sentinel lymph node pathological ultrastaging: Final outcome of the Sentix prospective international study in patients with early-stage cervical cancer

42. ‘Let me recommend… ’: use of digital nudges or recommender systems for overweight and obesity prevention—a scoping review protocol

43. Estimating population-level 25-hydroxyvitamin D concentrations in Australia and New Zealand using the sun exposure (SUNEX) microsimulation model

45. The Emergence of Critical Multilingual Language Awareness in Teacher Education: The Role of Experience and Coursework

47. Assessing the Development of L2 Speaking Skills in Inside-School and Outside-School Settings through Growth Modelling

48. Data-driven meal events detection using blood glucose response patterns

49. ENGOT-EN20/GOG-3083/XPORT-EC-042 – A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design

Catalog

Books, media, physical & digital resources